Significantly, EHD2 and CAV1 or CAV2 mRNA overexpression predicted shorter patient survival specifically in the PAM50-defined basal BC (Figure 7B), consistent with the predominant basal (myoepithelial) cell expression of EHD2 in mouse mammary epithelium (Figure 1B and D). This evidence concerns the gene CAV1 and breast cancer.